Funding for this research was provided by:
American Cancer Society (RSG CCE 128826)
National Institutes of Health (R37CA226969)
Received: 21 September 2020
Accepted: 13 January 2021
First Online: 8 February 2021
Ethics approval and consent to participate
: The study was reviewed and approved by the Institutional Review Board (IRB) and the Office of Human Research Ethics of the University of North Carolina at Chapel Hill. All patients signed an informed consent before the surgery. All animals’ experimental procedures were approved by Institutional Animal Care and Use Committee of University of North Carolina at Chapel Hill.
: Not applicable.
: VP and JEA are employees and stockholders of Oncoceutics. No potential conflicts of interest were disclosed by the other authors.